BF
ABBV icon

Blankinship & Foster’s AbbVie ABBV Stock Holding History

Blankinship & Foster’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
15,397
-1
-0% -$215 0.78% 15
2026
Q1 		$3.35M Sell
15,398
-114
-0.7% -$25.3K 0.74% 17
2025
Q4 		$3.54M Sell
15,512
-1
-0% -$228 0.77% 17
2025
Q3 		$3.59M Buy
15,513
+29
+0.2% +$5.91K 0.79% 17
2025
Q2 		$2.87M Buy
15,484
+65
+0.4% +$12.1K 0.67% 17
2025
Q1 		$3.23M Sell
15,419
-150
-1% -$29.2K 0.82% 17
2024
Q4 		$2.77M Hold
15,569
– – 0.68% 17
2024
Q3 		$3.07M Hold
15,569
– – 0.75% 16
2024
Q2 		$2.67M Hold
15,569
– – 0.69% 15
2024
Q1 		$2.84M Sell
15,569
-143
-0.9% -$24.6K 0.74% 15
2023
Q4 		$2.43M Buy
15,712
+144
+0.9% +$21K 0.69% 15
2023
Q3 		$2.32M Buy
15,568
+193
+1% +$28.3K 0.77% 13
2023
Q2 		$2.07M Buy
15,375
+353
+2% +$51.8K 0.67% 14
2023
Q1 		$2.39M Buy
15,022
+289
+2% +$44.2K 1.04% 13
2022
Q4 		$2.38M Hold
14,733
– – 1.04% 16
2022
Q3 		$1.98M Sell
14,733
-100
-0.7% -$14.3K 0.96% 15
2022
Q2 		$2.27M Buy
14,833
+750
+5% +$115K 1.05% 13
2022
Q1 		$2.28M Sell
14,083
-148
-1% -$21.5K 0.92% 16
2021
Q4 		$1.93M Sell
14,231
-558
-4% -$65.9K 0.73% 20
2021
Q3 		$1.59M Hold
14,789
– – 0.65% 20
2021
Q2 		$1.67M Hold
14,789
– – 0.66% 19
2021
Q1 		$1.6M Hold
14,789
– – 0.67% 20
2020
Q4 		$1.58M Hold
14,789
– – 0.66% 19
2020
Q3 		$1.29M Buy
+14,789
New +$1.39M 0.62% 20

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Blankinship & Foster's ABBV Position: Q2 2026 in Review

Blankinship & Foster reduced its AbbVie (ABBV) stake by 0.01% in Q2 2026, selling an estimated $215 and leaving 15,397 shares worth $3.87M. The position accounts for 0.78% of the portfolio, ranked #15.

Blankinship & Foster first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Blankinship & Foster held 15,397 shares of AbbVie worth $3.87M as of Q2 2026.
  • Blankinship & Foster sold 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.78% of Blankinship & Foster's portfolio in Q2 2026, its #15 holding.
  • Blankinship & Foster first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Blankinship & Foster's 13F filing for Q2 2026, filed 31 Jul 2026.